{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:18Z","timestamp":1786120338710,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/dad.0b013e3182318dd9","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T11:31:29Z","timestamp":1324726289000},"page":"330-334","source":"Crossref","is-referenced-by-count":5,"title":["Leukocytoclastic Vasculitis as Early Manifestation of Epstein-Barr Virus\u2013Positive Diffuse Large B-Cell Lymphoma of the Elderly"],"prefix":"10.1097","volume":"34","author":[{"given":"Pablo","family":"Zoroquiain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Molg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9R","family":"Valbuena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0738-081X(93)90115-S","article-title":"Vasculitis and cancer.","volume":"11","author":"Kurzrock","year":"1993","journal-title":"Clin Dermatol"},{"key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0002-9343(86)90660-1","article-title":"Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders.","volume":"80","author":"Longley","year":"1986","journal-title":"Am J Med"},{"key":"R3-18-20210202","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.1986.01660190043013","article-title":"Cutaneous paraneoplastic syndromes.","volume":"122","author":"McLean","year":"1986","journal-title":"Arch Dermatol"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/1529-0131(199806)41:6<1133::AID-ART23>3.0.CO;2-S","article-title":"Cutaneous vasculitis as a paraneoplastic syndrome in adults.","volume":"41","author":"Garcia-Porrua","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R5-18-20210202","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00296-007-0513-4","article-title":". Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.","volume":"28","author":"Simon","year":"2008","journal-title":"Rheumatol Int"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":". The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":". Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1600-0609.2005.00429.x","article-title":". Microarray-based classification of diffuse large B-cell lymphoma.","volume":"74","author":"Poulsen","year":"2005","journal-title":"Eur J Haematol"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","article-title":". Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease.","volume":"99","author":"Shimoyama","year":"2008","journal-title":"Cancer Sci"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/archinte.1994.00420030148015","article-title":"Clinical manifestations of vasculitis in patients with solid tumors. A case report and review of the literature.","volume":"154","author":"Kurzrock","year":"1994","journal-title":"Arch Intern Med"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","article-title":". Vasculitides associated with malignancies: analysis of sixty patients.","volume":"57","author":"Fain","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000089478","article-title":". Fulminant vasculitis: a rare fatal complication of lymphoma.","volume":"115","author":"Leshem","year":"2006","journal-title":"Acta Haematol"},{"key":"R13-18-20210202","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/ard.60.3.293","article-title":". Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia.","volume":"60","author":"Hamidou","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7819-6-13","article-title":". Does the surgeon still have a role to play in the diagnosis and management of lymphomas.","volume":"6","author":"Morris-Stiff","year":"2008","journal-title":"World J Surg Oncol"},{"key":"R15-18-20210202","first-page":"738","article-title":". Leukocytoclastic vasculitis in relation to amlodipine administration.","volume":"195","author":"del Rio Fernandez","year":"1995","journal-title":"Rev Clin Esp"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1468-3083.2008.02824.x","article-title":"Annular leukocytoclastic vasculitis after the administration of an amlodipine generic.","volume":"23","author":"Meissner","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2559.2009.03443.x","article-title":"The histological assessment of cutaneous vasculitis.","volume":"56","author":"Carlson","year":"2010","journal-title":"Histopathology"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D30PC7Q9DR","article-title":". Generalized B-cell non Hodgkins lymphoma in association with leukocytoclastic vasculitis and disseminated intravascular coagulation.","volume":"12","author":"Cardinali","year":"2006","journal-title":"Dermatol Online J"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/rheumatology\/41.4.476","article-title":"Urticarial vasculitis: a paraneoplastic presentation of B-cell non-Hodgkins lymphoma.","volume":"41","author":"Wilson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R20-18-20210202","first-page":"549","article-title":"Cutaneous extravascular necrotizing granuloma (Churg-Strauss) as a paraneoplastic manifestation of non-Hodgkins B-cell lymphoma.","volume":"86","author":"Calonje","year":"1993","journal-title":"J R Soc Med"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":". Senile EBV B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":". Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J Clin Exp Hematop"},{"key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1349-7006.2006.00155.x","article-title":". Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.","volume":"97","author":"Yoshino","year":"2006","journal-title":"Cancer Sci"},{"key":"R24-18-20210202","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":". The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"key":"R25-18-20210202","first-page":"1295","article-title":". EBV positive diffuse large B-cell lymphoma in the elderly: a diagnostic entity.","volume":"23","author":"Caponetti","year":"2010","journal-title":"Mod Pathol"},{"key":"R26-18-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humpath.2009.07.024","article-title":". Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.","volume":"41","author":"Hoeller","year":"2010","journal-title":"Hum Pathol"},{"key":"R27-18-20210202","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.thromres.2005.06.001","article-title":". Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy.","volume":"117","author":"Kamikura","year":"2006","journal-title":"Thromb Res"},{"key":"R28-18-20210202","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/jps.21210","article-title":". Wound healing dressings and drug delivery systems: a review.","volume":"97","author":"Boateng","year":"2008","journal-title":"J Pharm Sci"},{"key":"R29-18-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biotechadv.2009.11.001","article-title":". Novel chitin and chitosan nanofibers in biomedical applications.","volume":"28","author":"Jayakumar","year":"2010","journal-title":"Biotechnol Adv"},{"key":"R30-18-20210202","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.burns.2006.09.010","article-title":". The effect of chitosan hydrogel containing DMEMF12 medium on full-thickness skin defects after deep dermal burn.","volume":"33","author":"Kiyozumi","year":"2007","journal-title":"Burns"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000372-201205000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:37Z","timestamp":1786048297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-201205000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3182318dd9","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}